GSK
-
Life Sciences Beyond the Lab: Careers in Biotech and Pharma for STEM Students
STEM students charting career paths in Greater Philadelphia enjoy a strong advantage. The region, encompassing southeastern Pennsylvania, southern New Jersey,…
-
Johnson & Johnson Expands its Montco Footprint with $1B Investment
Johnson & Johnson is making another major bet on Montgomery County, writes Harold Brubaker for The Philadelphia Inquirer. The pharmaceutical…
-
Eli Lilly to Build $3.5B Weight-Loss Drug Plant in Upper Macungie
Eli Lilly plans to build a $3.5 billion pharmaceutical plant in Upper Macungie Township, just north of Montgomery County, for…
-
GSK’s Emma Walmsley Rejects Co-CEO Trend, Emphasizes Resilience in Leadership
GSK chief executive officer Emma Walmsley says she’s unconvinced of the rising co-CEO trend, writes Nina Paoli for Fortune. As…
-
WSJ: GSK CEO Emma Walmsley to Step Down; Luke Miels to Lead Pharma Giant
Pharmaceutical giant GSK is preparing for a major leadership change that will resonate globally and locally, reports Elena Vardon and…
-
King of Prussia’s SEED Therapeutics Pioneers “Molecular Glue” Cancer Treatments
King of Prussia’s SEED Therapeutics is tackling one of medicine’s toughest challenges, writes Holly Quinn for Technical.ly. The biotech startup…
-
GSK Picks Upper Merion for an AI-Powered Biologics Hub
GSK is turning to Upper Merion for its next-gen biologics “flex” factory, writes Harold Brubaker for the Philadelphia Inquirer. The…
-
WSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for…
-
GSK Partners with Chinese Pharma Co. in $500M Deal
Pharma giant Glaxosmithkline, which has major operations in Upper Providence and West Point, is partnering with China-based Hengrui Pharma, writes…
-
Glaxosmithkline Gets Approval for First-of-its-Kind Lupus Treatment
Glaxosmithkline, with multiple operations in Montco, just scored a major regulatory win that could reshape how lupus nephritis is treated…
-
Upper Providence’s GSK Bets Big on ‘Game-Changing’ Liver Disease Drug
GSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the Philadelphia…
-
GlaxoSmithKline Brings Meningitis Awareness to Lifetime with Original Film
Pharma giant GlaxoSmithKline, with major operations in Upper Providence, is heading to Hollywood with a mission, writes John George for…
-
Philadelphia Companies Make Forbes’ List of America’s Best Large Employers
Forbes has released its tenth annual list of has America’s Best Large Employers and Philadelphia was well-represented, writes Rachel Rabkin…
-
Discovery Labs Works on Massive Financing Deal to Settle Debt
Brian O’Neill, developer of Discovery Labs in King of Prussia, is completing a $1 billion financing package to recapitalize Innovation…
-
A Planned GSK Expansion Pushes Company Beyond Montgomery County
GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment of up…
-
Forbes Ranks U.S. Companies for Diversity; See Which Montco Firms Emerged as Notable
Forbes partnered with Statista — a platform in Germany that provides company insights — to assess diversity, equity, and inclusion…
-
Big-Pharma GSK Announces First Woman CFO; She Arrives as ‘Highly Experienced’ Leader
Big Pharma company GSK — which has a multi-site presence in Montgomery County (King of Prussia, Conshohocken, and Collegeville) —…
-
Penn Medicine Gene Therapy Doctor Signs Deal with Center for Breakthrough Medicines in King of Prussia
University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
